+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Liver And Kidney Disorders Drugs Market Research Reports

From
Liver Cirrhosis - Epidemiology Forecast - 2034 - Product Thumbnail Image

Liver Cirrhosis - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 112 Pages
  • Global
From
Idiopathic Membranous Nephropathy - Epidemiology Forecast - 2034 - Product Thumbnail Image

Idiopathic Membranous Nephropathy - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 69 Pages
  • Global
From
Diabetic Kidney Disease (DKD) - Epidemiology Forecast - 2034 - Product Thumbnail Image

Diabetic Kidney Disease (DKD) - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 95 Pages
  • Global
From
Acute Kidney Injury (AKI) - Epidemiology Forecast - 2034 - Product Thumbnail Image

Acute Kidney Injury (AKI) - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 90 Pages
  • Global
From
Alport Syndrome - Epidemiology Forecast - 2034 - Product Thumbnail Image

Alport Syndrome - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 63 Pages
  • Global
From
From
Clear Cell Renal Cell Carcinoma (ccRCC) - Pipeline Insight, 2025 - Product Thumbnail Image

Clear Cell Renal Cell Carcinoma (ccRCC) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Oncocytoma - Pipeline Insight, 2025 - Product Thumbnail Image

Oncocytoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Renal Impairment - Pipeline Insight, 2025 - Product Thumbnail Image

Renal Impairment - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Renal Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Renal Cell Carcinoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Primary Hyperoxyaluria - Pipeline Insight, 2025 - Product Thumbnail Image

Primary Hyperoxyaluria - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Hepatitis C Testing Global Market Report 2025 - Product Thumbnail Image

Hepatitis C Testing Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
Liver Disease Diagnostics Market Report 2025 - Product Thumbnail Image

Liver Disease Diagnostics Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Continuous Renal Replacement Therapy Market Report 2025 - Product Thumbnail Image

Continuous Renal Replacement Therapy Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
From
Chronic Kidney Disease Market Report 2025 - Product Thumbnail Image

Chronic Kidney Disease Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Diabetic Kidney Disease Market Report 2025 - Product Thumbnail Image

Diabetic Kidney Disease Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Loading Indicator

The Liver and Kidney Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs to treat diseases and disorders of the liver and kidneys. These drugs are used to treat a variety of conditions, including hepatitis, cirrhosis, kidney failure, and other kidney-related diseases. The market is highly competitive, with many companies vying for market share. The market is driven by the increasing prevalence of liver and kidney diseases, as well as the development of new treatments and technologies. Additionally, the rising demand for better treatments and the increasing availability of generic drugs are also contributing to the growth of the market. Some of the major companies in the Liver and Kidney Disorders Drugs market include Pfizer, Merck, Novartis, Sanofi, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, and AbbVie. These companies are engaged in the development and production of drugs to treat liver and kidney diseases. Show Less Read more